David FisherSep 6, 2023
Great to be at the 2023 #Cochrane #Colloquium #London this week: fantastic people, great venue, and sunshine! Yesterday I described how we maximized the value of #IPD within the #STOPCAP collaborative #metaAnalysis project in advanced #prostateCancer https://doi.org/10.1016/S1470-2045(23)00230-9
David FisherJul 7, 2023

Our #STOPCAP #IPDMA of #docetaxel for advanced #prostateCancer #mHSPC came out this week in #LancetOncology!

Very excited about this: result of tremendous collaborative effort to obtain harmonized trial data, apply meticulous checking & processing, and carry out high-quality statistical analysis. Aim was to clarify patterns of survival within patient subgroups most & least likely to benefit.

https://doi.org/10.1016/S1470-2045(23)00230-9